[The "clinical cost" of implantable cardioverter-defibrillators in the primary prevention of sudden cardiac death should not restrict their use]

G Ital Cardiol (Rome). 2011 May;12(5):379-82; discussion 382. doi: 10.1714/643.7504.
[Article in Italian]
No abstract available

Publication types

  • Comment

MeSH terms

  • Arrhythmias, Cardiac / epidemiology
  • Arrhythmias, Cardiac / therapy
  • Comorbidity
  • Death, Sudden, Cardiac / epidemiology
  • Death, Sudden, Cardiac / prevention & control*
  • Defibrillators, Implantable / adverse effects*
  • Defibrillators, Implantable / psychology
  • Equipment Design
  • Equipment Failure
  • Follow-Up Studies
  • Heart Failure / classification
  • Heart Failure / mortality
  • Heart Failure / therapy
  • Humans
  • Patient Acceptance of Health Care
  • Patient Selection
  • Quality of Life
  • Randomized Controlled Trials as Topic
  • Risk
  • Stroke Volume